The Early-Stage ALS Clinicians grant is focused on supporting the ideas of the next generation of ALS clinicians and clinician scientists. This grant provides three years of salary and supplies to enable talented clinicians to pursue academic research in addition to their clinical practice, with the goal of making long-term improvements in the healthcare of ALS patients.
Key Dates
What We’re Funding
Target ALS is especially interested in proposals that address or incorporate the following topics:
- Identification, validation and development of new ALS biomarkers and diagnostic criteria
- Understanding clinical contributions from FTD
- Data-driven examination of multimodal biomarkers for the definition of prognosis
- Prospective-retrospective biomarker integration to evaluate clinical outcomes
- Risk and stratification models for clinical trial inclusion
- Clinical outcome measures
- Therapeutic targets
- Tools and technologies to facilitate human proof-of-biology studies
Confidentiality of the investigator’s data, research, and intellectual property will be strictly honored. Target ALS Foundation does not seek ownership of any intellectual property or financial gains that results on the basis of its funding.
Who Should Apply
To be eligible for this grant, applicants should:
- Be an early-stage ALS clinician or clinician scientist who received their clinical appointment on or after August 14, 2018.
- Commit to being clinically active during and after the award. During the award, 20-40% of their time should be spent caring for ALS patients.
- Hold an M.D. or equivalent degree (e.g. M.B.B.S. or M.B.B.Ch.).
Each investigator can apply for only one project through this funding opportunity. If an investigator is already a recipient of another Target ALS grant, it is crucial to draw a clear distinction from the currently funded project
What Our Grants Support
Early-Stage ALS Clinicians grant funding will cover the following project components:
- Researcher salaries and fringe benefits.
- Lab supplies, materials, and equipment
- Research associated costs up to 15% of the award (e.g. lab’s rent)
- Costs of accessing Target ALS core facilities throughout the period of the award.
- A speaker slot at the Target ALS annual meeting, held in Boston, MA. This meeting provides an immersive experience in cutting edge ALS research and offers an opportunity to network with leaders from academia, pharma/biotech, venture capital and other non-profits.
Grant Structure
- $150,000 per year for three years, for a total possible grant of $450,000.
- The initial grant will be for a two-year period.
- Grant recipients will be eligible to compete for a third year of funding based on a competitive review of updated project goals as well as compelling progress at the end of the second year of funding.
